Budget 2023: Chancellor follows advice from chief scientific adviser to rely on foreign approval processes
The UK is to move to a new model for regulating drugs and medical technologies with the goal of speeding up approvals, chancellor Jeremy Hunt has announced.
In his spring budget on 15 March, Hunt said the Medicines and Healthcare Products Regulatory Agency would become “faster and nimbler”.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.